SCHEMBL29800829

SCHEMBL29800829

COc1cc(NS(=O)(=O)c2ccccn2)c2ncccc2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 4/20 0.78
SLC40A1 Q9NP59 10/20 0.76
MEN1 O00255 5/20 0.73
KMT2A Q03164 5/20 0.73
TDP1 Q9NUW8 5/20 0.73
POLB P06746 1/20 0.73
CXCR2 P25025 2/20 0.69
LMNA P02545 1/20 0.69
TP53 P04637 1/20 0.69
MAPT P10636 1/20 0.69
HPGD P15428 1/20 0.69
TSHR P16473 1/20 0.69
AGTR1 P30556 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
NFKBIA P25963 1/20 0.63
RELA Q04206 1/20 0.63
CXCR4 P61073 1/20 0.61
CKS1B P61024 1/20 0.60
SKP2 Q13309 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26964245 1.00 GLO1 (0.78) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL7197593 0.86 SLC40A1 (1.00) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL30925561 0.86 MEN1 (0.74) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL11995657 0.85 SLC40A1 (1.00) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL22076984 0.84 MEN1 (1.00) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL13633886 0.84 MEN1 (1.00) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL30925544 0.84 SLC40A1 (0.74) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL27214179 0.84 SLC40A1 (0.74) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL13633861 0.83 SLC40A1 (0.73) GLO1SLC40A1MEN1KMT2ATDP1
SCHEMBL30854819 0.83 CXCR2 (0.77) SLC40A1MEN1KMT2ATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291555-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-12-20 EP disclosed
CN-116806218-A Sulfonamide and its use for the treatment of parasitic helminth infections and diseases 新基公司 2023-09-26 CN disclosed
WO-2022173727-A1 SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-08-18 WO disclosed